Broker snap: Smith and Nephew seen facing tough year
Free email from MoneyWeek
Money
Morning is the FREE daily email from MoneyWeek – a punchy round-up
of the latest investment news and profit opportunities. DON’T MISS
IT!
This genius investor does dizzying levels of research to uncover...Half Price Shares!
Goldman Sachs has downgraded its rating on Smith and Nephew to 'sell' from 'neutral' and cut its price target to 530p from 710p, saying it expects the medical devices firm's earnings shortfall to accelerate over the rest of 2008.
Advertisement
FREE! For all our latest advice on making profitable investments, claim your 3-week FREE trial of the MoneyWeek website and magazine now.
Money Morning is the FREE daily email from MoneyWeek
– a punchy round-up of the latest investment news and profit opportunities.
DON’T MISS IT!
